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The phenomenon ofTh receptor recognition ofprotein antigens has been inten-
sively studied during recent years, leadingto a more comprehensiveunderstanding
of the physical and chemical requirements that determine the mode of interaction
betweenantigen, the MHC-restrictingelement (class II geneproducts), andtheTCR
complex (1-4). The current working hypothesis to explain the process of antigen
presentation states that the protein antigen must be proteolytically digested (4-6)
or at least denatured (7) inside acidic compartments (probably endosomes) within
theAPC (e.g., Bcells, macrophages, dendritic cells) (8-10) . Thepathways ofantigen
degradation and subsequent emergence ofthe immunogenic peptide ontothe plasma
membrane of the presenting cell in conjunction with the appropriate class II (Ia)
heterodimerare still unknown, although itappearsmost likely thatthe peptide forms
a stable complex with the Ia molecule before the TCR recognition event (I1-13).
Recent data emerging from several laboratories (14, 15) have provided strong evi-
dencethat there exists only asingle site on the class II heterodimerthat caninteract
directlywith the immunogenic peptide. In the case ofthe murine system, any given
individual may express alimited numberofIa molecules, thus, the peptide-binding
site on the class II heterodimer must be of extremely broad specificity in order to
accept the large variety of antigenic peptides likely to be encountered.
The learning ofMHC restrictionis acquiredinthe thymus where immature thymo-
cytes are selected on the basis of their ability to recognize antigen in the context
of self-MHC (16, 17). It is at this stage that tolerance to self antigen is acquired;
at least in the case ofantigens present in the thymic environment (18-20). However,
tolerance to antigens never expressed in the thymus must be established after the
mature T cell has arrived in the periphery. Despite evidence that a deletion event
for self-reactive T cell clones is operative in the thymus (20), there have been many
examples where the existence of self-reactive T cell clones has been demonstrated
to both self-MHC antigens (21, 22) and non-MHC self antigens (23, 24). Thus,
in these instances, it appears that clonal deletion is not effective. Active regulatory
systems, involving suppressor T cells, have been proposed to account for the sup-
pression of such self-reactive T cell clones under normal circumstances (25, 26).
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The study of the immunological recognition of cytochromes c (cyt c)t has played
a critical role in elucidating the physical and chemical nature ofT cell epitopes derived
from protein antigens (2, 27-29). However, as yet, there has been no investigation
of the immunological properties of the heme moiety of cyt c. The heme group is
covalently bound to the polypeptide backbone ofthe protein through cysteine residues
at position 14 and 17. Here we show that the heme moiety of cyt c is a dominant T
cell epitope that induces a large proliferative response in lymph node T cells derived
from SJL and 1310 .A mice. Not only is this vigorous response observed for cyt c-primed
T cell populations but also for populations obtained from naive SJL or B10A mice.
In the case of both primed and naive T cell populations, the reactivity to the heme
moiety falls under strict MHC restriction, thus behaving as a "classical" T cell epi-
tope. Therefore, these findings require that the current models describing the na-
ture of T cell epitopes be extended to include nonpeptide molecules. Furthermore,
as the heme moiety is ubiquitous throughout the organism, although sequestered
within proteins, the existence ofheme-reactive T cell populations in unprimed animals
provides another example of the existence of self-reactive T cell clones.
Materials and Methods
Antigens.
￿
Bovine heart cyt c (type V) (bov cyt c) and pigeon breast muscle cyt c (type XIII)
were obtained from the Sigma Chemical Co. (St. Louis, MO) and were used without further
purification. The chloride salt of the heme moiety, hemin chloride (HmCI), (Calbiochem-
Behring Corp., LaJolla, CA) was used in all in vitro proliferation assays. In this form, the
iron atom of the penta-coordination complex is in the ferric (Fe3*) oxidation state. The CNBr
cleavage fragment of bov cyt c (1-65) was prepared from the native apo-protein according
to the method of Corradin and Harbury (30).
Apo-bov cyt c was prepared according to the method of Sano and Tanaka. (31). 1 ml of
glacial acetic acid and 7.5 ml of 0.8% Ag2SO4 (in H2O) were added to 38 mg of bov cyt
c dissolved in 5 ml of distilled H2O. After incubation at 37°C for 6 h, 85 ml of acid acetone
(1 ml 5N H2SO4/100 ml of acetone) was used to precipitate the protein, which was then pel-
leted by centrifugation. The protein precipitate was redissolved in the smallest possible volume
of 0 .2 M acetic acid. To remove the free heme from the protein environment, the solution
was then dialyzed overnight under nitrogen, against 1 litre of0.2 M acetic acid. All reactions
until this stage of the procedure were carried out in the dark using light-proof containers.
Once the free heme had been removed, the protein solution was dialyzed exhaustively against
distilled H2O. This procedure replaces the heme moiety (covalently bound to the polypeptide
backbone of the cyt c molecule through cysteines at positions 14 and 17) with Ag ions. As
a consequence of this substitution, the Ag-cyt c complex is insoluble under nonacidic condi-
tions. To remove the Ag ions, the protein was lyophilized and then redissolved in 10 ml of
0.05 M ammonium acetate and 0.15 ml of pure 2-ME. The solution was incubated at 37°C
for 5 h. A white precipitate of silver sulfide was then removed by centrifugation, and the
supernatant, containing the apo-protein, was lyophilized. The final purification step was car-
ried out on a Sephadex G-25 column (1 x 30 cm) previously equilibrated with 0.01 M ammo-
nium acetate. The protein peak was collected after elution with 0.01 M ammonium acetate
and lyophilized.
Animals.
￿
SJL/J, B10.A(4R), A.SW/SgSn, BALB/cByj, and C57BL/6J were obtained from
the breeding colony of Scripps Clinic and Research Foundation (La Jolla, CA). In general,
female mice, 6-10 wk old, were used.
Preparation of Lymph Node T Cells.
￿
Mice were primed with either pigeon cyt c, bov cyt c
(100 !tg in total), or PBS emulsified 1 :1 in CFA (H37 Ra; Difco Laboratories Inc., Detroit,
' Abbreviations used in this paper: bov cyt c, bovine cytochrome c; cRPM1, complete RPMI 1640
medium; cyt c, cytochrome c; HmCl, hemin chloride; LN, lymph node; Rf, relative mobility.COOPER ET AL .
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MI) . Injections were given interperitoneally at the base ofthe tail and into the hind footpads
(100 i .1 per animal) . 8 d later, the inguinal, pert-aortic, and popliteal lymph nodes were re-
moved . The lymph nodes were then ruptured, and the single cell suspension obtained was
washed twice in HBSS (Gibco Laboratories, Grand Island, NY). To further enrich the lymph
node (LN)T cell population, the single cell suspension was adsorbed onto a nylon wool column
as described by Julius et al . (32) . The column was incubated for 45 min at 37'C, and the
T cells were eluted using complete RPMI 1640medium (cRPMI)(M.A . Bioproducts, Walkers-
ville, MD) containing 10% heat-inactivated FCS (HyClone Laboratories, Logan, UT), 10%
NCTC-135 medium (Gibco Laboratories), 50 mM 2-ME, 4 mM glutamine (M.A . Bio-
products), and 100 U/ml of penicillin/100 gg/ml streptomycin (M.A . Bioproducts) .
Preparation ofAPC .
￿
Naive spleen cell populations were used as the source ofAPC in the
in vitro T cell proliferation assays. Spleens were removed from unimmunized mice of the
same strain as that from which the LN T cell population had been obtained. The spleens
were teased into a single cell suspension, washed twice with HBSS, and then irradiated at
3,000 rad, unless otherwise stated, using a "'Cs source.
When appropriate, spleen cells were fixed using 1% paraformaldehyde as follows: spleen
cells (5 x 106/ml) were incubated in HBSS containing 1% paraformaldehyde (J . T. Baker
Chemical Co., Phillipsburg, NJ) for 30 min at room temperature . The fixed cells were then
immediately diluted (x 3) with RPMI containing 1 M glycine and were then washed three
times in RPMI . After a further incubation in cRPMI for 30 min at 37°C, the cells were
again washed twice with RPMI before addition to culture wells .
In Vitro T Cell Proliferation Assay.
￿
T cell proliferation assays were carried out essentially
as described by Corradin et al . (33) . Briefly, 100 pl of antigen of appropriate dilution (in
cRPMI) and 100 Wl of cell suspension containing both 4.0 x 106 LN T cells/ml and 4.0 x
10 6 APC/ml in cRPMI were added to each well of a 96-well flat-bottomed plate. Final cell
concentations were 4.0 x 10 5 LN T cells and 4.0 x 10 5 APC per well . The cells were cultured
at 37°C and maintained in an atmosphere of 10% COZ for 3 d . The culture wells were then
pulsed with 0.5 gCi of [methyl-3H]thymidine (Amersham Corp ., Arlington Heights, IL) and
harvested 18-20 h later using a Mini-Mash cell harvester (M.A . Bioproducts) . Proliferation
was quantitated to determine (3H]thymidine incorporation by proliferating T cells using a
liquid scintillation counter (Rack-Beta; LKB Instruments, Inc ., Gaithersburg, MD) .
In some experiments, the degree of T cell proliferation was expressed as the fraction of
themaximum proliferation observed in the presence of 10 AM Con A (Calibiochem-Behring
Corp.) .
rnAb Blocking Studies.
￿
The B cell hybridoma lines MK-S4 and 10-2.16 expressing the anti
I-As (IgG2b) mAb and the anti-I-Ak (IgG2b) mAb, respectively, were purchased from the
American Type Culture Collection (Rockville, MD) . The MK-S4 antibody has been described
fully by Kappler et al . (34) ; Oi et al . (35) have characterized themAb expressed by the 10-2.16
cell line . The isotype control mAb 10-12 (IgG2b) was raised against the hapten DNP and
was a gift from Dr. Norman Klinman (Research Institute of Scripps Clinic) . The MK-S4
and 10-2.16 supernatants and the affinity-purified anti-DNP antibody were dialysed, exten-
sively, against PBS before addition to culture wells. For the in vitro blocking studies, 50 Al
of serially diluted antibody supernatant was initially added to each culture well, followed by
100 ul of appropriately diluted antigen and 50 ul of cell suspension (8.0 x 10 6 LNT cells/ml
plus 8.0 x 106 APC/ml) . Data are expressed as percentage ofmaximum proliferation where :
percent maximum proliferation = (LN T cell proliferation in the presence of blocking anti-
body)/(LN T cell proliferation in the absence of blocking antibody) .
Gel Filtration Chromatography .
￿
The heme-protein complex was isolated using gel filtration
chromatography. A solution ofHmCl (4.0 x 10-4M) incRPMI, containing 257o DMSO was
applied to a Sepharose 6B (Pharmacia Fine Chemicals, Piscataway, NJ) column (1 x 40 cm) .
The material was eluted usingPBS. The elution profile was monitored at both 280 and 405nm .
PAGE.
￿
PAGE was carried out as described (36) . Briefly, a 15% acrylamide resolving gel,
pH 8.8, and a 3ojo acrylamide stacking gel, pH 6.8, were used . When appropriate, 2% SDS
was added to each gel . The relative mobility (Rf) values ofthe protein and heme bands were
calculated as follows : Rf = (distance travelled through gel by heme/protein)/(distance travelled
by small molecular weight marker [Bromphenol blue]) .1130
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Results
The Proliferative Response ofSJL Lymph Node TCells to theHemeMoiety ofcytc.
￿
SJL
mice can be induced to produce a high titer ofanti-mouse cyt c antibodies when
immunized with mouse cyt c emulsified in CFA (Cooper, H. M., N. R. Klinman,
and Y. Paterson, manuscript in preparation). While studying the response of SJL
LN T cells to mouse cyt c, it was observed that the heme moiety of cyt c, in the
formofHmCl, induced a strong proliferative response in vitro. To characterize this
response further, SJL mice were immunized with bov cyt c. 8 d later, the lymph
nodes were removed, and a single cell suspension ofenriched T cells was obtained
bynylonwool purification asdescribed inMaterials and Methods. Fig. 1 arepresents
the typical dose-response curve observed for SJL LN T cells when responding to
bov cyt c or HmCI in vitro. It can be seen that the proliferative response to HmCI
was significantly greater than that to bov cyt c. The maximum response occurred
at a HmCl concentration of 25 gM. The magnitude of this response approached
that induced by Con A (10 gM), a nonspecific polyclonal T cell activator. In fact,
in someexperiments, thedegree ofproliferationinducedby HmCIwas greater than
that of Con A. In contrast, the proliferative response to bov cyt c was significantly
weaker. Stimulation ofLN T cell proliferation by 100 gM bov cyt c was only 30%
ofthe response to Con A. Fig. 1 b shows the proliferative response of LN T cells
from SJL mice that had been immunized with PBS emulsified (1:1) in CFA, as de-
scribed above. Again, a large proliferative response was observed in the presence
ofHmCI(in vitro). Both thedose-responsecurveforHmClandthe maximumprolifer-
ation observed were equivalent to that for LN T cells from bov cyt c immunized
mice. Furthermore, LN T cells from SJL mice that had received no immunization
of any kind behaved in an identical manner to PBSICFA-primed SJL LN T cells
when stimulated by HmCl in vitro (data not shown). Overall, for both bov cyt c-
and PBS-primed SJL LN T cells, the dose-response curve for HmCl was found to
be highly reproducible overmanyexperiments. In most cases, themaximum prolifer-
ative response was equal to or greater than thatto Con A and occurred at an HmCI
concentration of 25 gM. It is also ofinterest to note that a significant proliferative
response to bov cytcwas always observed for LN T cells from SJL mice immunized
with PBS/CFA only.
As HmCl is insoluble in aqueous solution, it was used as a stock solution (2.0
x 10-
2 M) in DMSO. This solution was then serially diluted (100-3,200-fold)
across the culture wells to give a final concentration range of 100-3 pM, and there-
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FIGURE 1.
￿
Theproliferative response
ofnylonwool-purified LN Tcells from
SJL mice to the heme moiety ofcyt c.
The response of LN T cells from (a)
bov cyt c-immunized SJLs and (b)
PBS-immunized SJLs,to in vitrostim-
ulationby HmCl (+DMSO)("), bov
cyt c (no DMSO) ("), bov cyt c
(+DMSO) (A), ConA (10 Wg (/), or
no antigen (EI).COOPER ET AL.
￿
113 1
fore, acorrespondingconcentration range of1.0-0.03% DMSO. Fig. 1, a andb show
the dose-response curve to bov cyt cin the presence and absence ofthe appropriate
range ofDMSO concentrations. It is clear that the presence ofDMSO did not en-
hance, nonspecifically, the proliferativeresponse to antigenin vitro. Athigh concen-
trations ofDMSO (1 01o in the culture well) the responsetobovcytcwas significantly
reduced, probably due to cell death.
The Proliferative Response to the Herne Moiety ofcyt c is Under Class HMHC Restric-
tion. As both LN T cells from PBS- and bov cyt c-primed SJLs responded in vitro
to HmCl, it waspossible that thehememoiety mayhavebeen acting asanonspecific
T cell activator, analogous in its effects to Con A. Therefore, the ability of HmCl
to stimulate a proliferative response to LN T cells from other congenic strains of
mice wasinvestigated (Table I). Neithernylonwool-enriched LN Tcellsfrom BALB/c
(I-Ad, I-Ed) nor C57BL/6 (I-Ab) mice that had been primed with bov cyt c or PBS
responded to stimulation (in vitro) with HmCl. The lack ofresponse to HmCl in
these strains could not be attributed to the general inability ofthese LN T cells to
proliferate in vitro as their proliferative response to 10 AM Con A was equivalent
to that observed for SJL LN T cells as measured by [3H]thymidine uptake (4 x
104-105 cpm per 4.0 x 105 T cells). Furthermore, LN T cells from BALB/c mice,
immunized with sperm whale myoglobin, did not proliferate to in vitro stimulation
with HmCl but responded well to stimulation with myoglobin (26% of the Con
A-stimulated T cell proliferative response) (data not shown).
TABLE I
MHC Class II Restriction of the LN T Cell Proliferative Response
to the Heme Moiety of Cyt c
Percent Con A-stimulated T cell response = [3H]thymidine uptake (cpm) in the presence
of stimulating antigen/[3H]thymidine uptake (cpm) in the presence of 10 PM Con A
( + DMSO) . Results are shown for two animals from each strain immunized with either cyt
c or PBS. Assays were generally performed in triplicate. The proliferative response to Con
A (10 ug) for all assays was within the range of 40-100,000 cpm . per 4.0 x 105 LN T cells.
Background proliferation in the absence of antigen was never observed to be >3-5% of Con
A-stimulated proliferation.
Bov cyt c (100 wM + 1 % DMSO) was used as stimulating antigen for all mice strains except
B10.A and B10.A(4R) where pigeon cyt c (50 jtM, 0.5% DMSO) was used.
§ No response above background.
Stain
Class II
expressed
Percent Con A-stimulated T cell
Cyt c immunized PBS
HmCI HmCI
12 .5 uM 25 pM Cyt Cl 12.5 gM
proliferation'
immunized
25gM Cyt cl
SJL I-As 46 56 25 61 56 6
34 65 17 95 72 8
A.SW I-As 59 72 2 42 54 -§
23 24 14 38 39 3
B10.A I-Ak,I-Ek 61 74 21 153 125 3
166 170 56 89 95 -
BlO.A(4R) I-Ak 131 194 31 162 123 2
C57BL/6 I-Ab 2 3 - - - 1
- 4 2 4 3 4
Balb/c I-Ad,I-Ed - - 3 - - -1132
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In contrast to the H-2b and H-2d strains LN T cells obtained from A.SW (I-A9,
only), B10.A (I-Ak, I-Ek) and B10.A(4R) (I-Ak only) strains responded vigorously to
HmCl (Table I). Thus, it appears that the T cell proliferative response to the heme
moiety of cyt c was not due to a nonspecific polyclonal activating event. Instead,
the recognition ofHmCl was restricted to those T cells derived from mouse strains
expressing class II molecules ofthe "s" or "k" haplotype. Since both SJL and A.SW
mice express only I-AS on their APC, and were high responders, it seems likely that
the I-A9 molecule was the restricting element in the SJL and A.SW T cell recogni-
tion ofHmCl. Similarly, the I-Ak molecule also appears to present the heme moiety,
since both B10.A (I-Ak, I-Ek) and B10.A(4R), which only express I-Ak, were also
high responders.
mAbs againsttheI-A HeteodimerBlocktheProliferativeResponse ofLNTCellstoHmCl.
￿
To
confirmthat the heme moiety ofcyt c is presented to the SJL LN T cells in conjunc-
tion with the I-A' heterodimer, the mAb MK-S4 (anti-I-As) was used to block the
specific proliferative response. From Fig. 2, a and b, it is clear that the MK-S4 anti-
body could totally inhibit the ability ofboth bov cyt c and HmCl to stimulate the
in vitro proliferationofLN T cellpopulationsderived from either cyt c-primed(Fig.
2 a) or PBS-primed (Fig. 2 b) animals. Similarly, the anti I-Ak (10-2.16) could in-
hibit theheme-specificproliferative response ofLN Tcells derivedfrom B10.A mice
primed with either pigeon cyt c (Fig. 2 d) or PBS (Fig. 2 e). Also, partial inhibition
of pigeon cyt c stimulated proliferation was observed for LN T cells from pigeon
cyt c-primed B10.A mice (Fig. 2 d). LN Tcells from PBS-primed B10.A mice did
not respond topigeon cyt c. Fig. 2, candfshow that bothmAbs, MK-S4 and 10-2.16,
respectively, did not interfere with the ability ofKLH-primed BALB/c LN T cells
(H-2d) to respond to in vitro stimulation by KLH. Thus, the inhibition observed
in Fig. 2, a, b, d, and e is not due to nonspecific inhibitory effects ofthese antibody
preparations. Furthermore, the isotype-matched anti-DNP mAb had no effect on
the ability of either cyt c or HmCl to induce LN T cell proliferation in vitro (data
not shown). Therefore, the inhibition ofproliferation observed in the presence of
the anti-I-As and anti-I-A' mAbs suggests that HmCl stimulates T cell proliferation
in association with the I-As or I-A' heterodimer.
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FIGURE 2.
￿
Blocking of the proliferative
response ofSJLLN Tcells by an antigen-
I-AS mAb (MK-S4) (a and b) or B10.A
LN Tcells by an anti-I-Al mAb (10-2.16)
(d and e). The ability of LN Tcells from
bovcytc- or pigeon cyt c-primed mice (a
and d, respectively) or PBS-primed mice
(b and e) to proliferate in response to the
appropriate cytc; bovcyt c (50 pM)(A);
pigeon cyt c (50 vM) (A); or HmCI (25
gM) (") in the presence of blocking an-
tibody. The mAbs MK-S4and 10-2.16 did
notinhibittheKLH-specific proliferative
response of BALB/c LN T cells (c andf,
respectively).Paraformaldehyde-fixed Spleen Cells Can Present the Heme Moiety ofcyt c to SJL LN T
Cells. To define more clearly the mechanism by which the heme moiety of cyt c
is recognized when presented in conjunction with the I-A'heterodimer on the sur-
face ofthe APC, splenic cell populations obtained from SJL mice were fixed with
l 0 Jo paraformaldehyde as described in Materials and Methods. The ability offixed
andnonfixedspleen cells to presentbovcytc, HmCl, andthe heme-containingfrag-
ment 1-65 ofbov cyt c (bov [1-65]) to LN T cells obtained from SJL mice primed
with either bov cyt c or PBS were compared (Fig. 3, a and b, respectively). Firstly,
it can be seen that the pattern of the proliferative responses to the various antigens
tested was very similar for bovcyt c- and PBS-primedmice. Secondly, as expected,
bov cyt c induced a significant proliferative response when presented by nonfixed
APC (Fig. 3 solidlines) but notwhen paraformaldehyde-fixedAPC were used (Fig. 3
broken lines). In contrast, the heme moiety of cyt c was presented efficiently by the
fixed APC such that a strong proliferative response was observed for LN T cells
from both bov cyt c- and PBS-primed mice. The magnitude ofthe proliferative re-
sponse, however, was not as great as thatobserved in the presence ofnonfixed APC.
The reduced ability of fixed APC compared with nonfixed APC to present peptide
antigens has previously been observed(37, 38, 39). This decreasecould bethe result
ofthe paraformaldehyde fixation procedure, which may reduce the numberoffunc-
tional la heterodimers on the cell surface ofthe presenting cell due to crosslinking.
Finally, aswasobserved previously in thecase ofbov cyt cstimulation ofthePBS-
primed SJL LN T cell population (Fig. 1 b)response to bovcyt c, the heme-containing
fragment 1-65, could also induce a significant response in T cells derived from
PBS/CFA-immunized mice. Furthermore, from Fig. 3, a and b it can be seen that
this fragment is recognized only when nonfixed APC were used. No specific Tcell
proliferation to bov (1-65) was observed in the presence ofparaformaldehyde-fixed
APC. Thesedata would suggest that theheme-containing fragment ofbov cyt c re-
quires further processing before a specific T cell proliferative response is observed.
Removal ofthe Heme Groupfrom cyt c Results in the Loss ofits Ability To Induce TCell
Proliferation. Since the CNBr cleavage fragment bov (1-65), as well as the whole
cyt cmolecule, were notpresented byfixedAPC, itwaslikely that aprocessing event
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b
FIGURE 3.
￿
The proliferative response
of SJLLN Tcells to the heme moiety
of cyt c presented by fixed APC. The
ability of(a) bov cyt c-primed and(b)
PBS-primed SJLLN T cells to prolif-
eratein response toHmCl ("), bovcyt
c (A), or bov(1-65) (N)when presented
by normal SJL APC (-) or APC
fixed with 1% paraformaldehyde (-----).1134
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was required before presentation ofthe correct epitope could take place. In the light
of theabove data, it was possible that theepitopebeing recognized within the frame-
work of the polypeptide chain of the cyt c molecule was in fact the heme moiety
alone. To address this question, the heme group was chemically removed from the
cyt cmolecule as described in Materials andMethods. Theapo-bov (1-65) fragment
was then cleaved from apo-bov cytcusingCNBr (see Materials andMethods). These
modified antigens were then tested for their ability to induce both bov cyt c- and
PBS-primed SJL LN T cellsto proliferate in vitro. Fig. 4a and b clearly demonstrate
that removal of the heme prosthetic group from both the whole molecule and the
CNBr cleavage fragment, bov (1-65), resulted in the abrogation of T cell recogni-
tion of these antigens. The loss of T cell reactivity could not be attributed to T cell
death due to chemical contamination of the apo-cyt c preparation sincethe degree
of Con A-induced T cell proliferation was not reduced in the presence of 100 ltl
apo-bov cyt c or apo-bov (1-65) (data not shown). Therefore, these results strongly
suggest that the heme moiety, perse, or perhapsin conjunction with a small number
of amino acid residues deriving from thecytcmolecule, is the T cell epitope respon-
sible for the bov cyt c-specific SJL LN T cell proliferation observed in our in vitro
assays (Figs. 1, 3, and 4). It is quite possible that a population of T cells from bov
cyt c-primed SJLs would be specific for epitopes residing within the polypeptide
backbone of the molecule. Such populations would go undetected in our assay if
their frequency was relatively low. Fig. 4 a demonstrates some residual stimulating
activity of apo-bov (1-65) for bov cyt c-primed LN T cells.
Enhanced Presentation oftheHeme Moiety by Radio-sensitiveAPC.
￿
Resting B cells are
known to be radiosensitive such that their ability to act as APC is inhibited when
they are irradiated at 3,300 rad but not 1,000 rad. This radiosensitivity allows the
antigen-presenting function of resting B cells to be distinguished from that of mac-
rophage and dendritic cells which are radioresistant to 3,300 rad (39, 40). Thus,
to examine the nature of the presenting cell on which the heme moiety of cyt c is
recognized in conjunction with the appropriate class II heterodimer, an SJL splenic
cell suspension was subjected to either 1,000 or 3,000 rad before addition to culture
wells. Theabilityof thedifferentially irradiated splenic cell suspensions to stimulate
the in vitro T cell proliferative response to HmCl is shown in Table II. From the
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Theproliferative response of
nylonwool-enriched LN Tcells from SJL
mice to apo-bovcytcandapo-bov(1-65).
The response of LN T cells from (a) bov
cytc-immunized SJLs and(b)PBS-immu-
nized SJLs to in vitrostimulation by HmCl
(*), bovcyt c("), apo-bovcytc(A), bov
(1-65) (/), apo-bov(1-65) (O), ConA(10
jig) (0), or no antigen (O).COOPER ET AL.
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TABLE 11
Comparison of the Ability of Spleen Cells Irradiated at 1, 000 or 3, 000 rad
to Present the Heme Moiety of cyt c to SJL LN T Cells
Percent Con A-Stimulated T cell proliferation'
cyt c immunized
￿
PBS immunized
' Thevalues givenare the average ofduplicatecultures within each experiment.
two experiments represented, it is clearthat the HmCl-specific SJL LN Tcell prolifer-
ation was significantly enhanced in the presence of splenic cells irradiated to 1,000
rad. These data indicate that a subpopulation of APC are radiosensitive and are
functional only after alight irradiation dose. Thus, it is likely that theheme moiety
of cyt c can be presented to T cells of the appropriate specificity by resting B cells
as well as macrophage and/or dendritic cells within the splenic cell population.
The Heme Group Forms a Stable Complex with BSA in Culture.
￿
As stated previously,
theheme moiety ofcyt c, when in theoxidized form ofHmCl, is insoluble in aqueous
solution. Therefore, the HmCl was initially dissolved in DMSO to give a stock solu-
tion of 2.0 x 10-2 M. For use in in vitro proliferation assays, the stock solution was
then diluted 100-3,000-fold in cRPMI. However, when these dilutions were made
in the absence of FCS, the heme moiety was observed to precipitate immediately.
Thus, an interaction between the heme group and a component of FCS appeared
to be required to maintain the solubility of HmCl. As the majorcomponent of FCS
is protein, it seemed likely that one or more protein species were interacting with
the heme group. Therefore, an HmCl solution in cRPMI (4.0 x 10-4 M) was chro-
matographed on a Sepharose613 gelfiltration column as described in Materials and
Methods. The elution profile is shown in Fig. 5. The eluant was monitored at 280
18 28 37 48 55
Elution Volume (m()
2.2
2.0 2.0
1.8 n
1.8
1.5 1.8 I
1.4 1 .4
1.2 1.2
C
FIGURE 5. Elution profile of heme-protein complex.
v °° _ 2 ml of a 4.0 x 10-4 M solution of HmCl dissolved in
1.0 1 .0 cRPM1wasapplied to aSepharose613 column (1 x 40
0.8 0.8 cm). The column was eluted in PBS and monitored at
0.8 0.8 both 405 and 280 nm.
0.4 0.4
0.2 0.2
Exp. rad
HmCl
12.5 Am 25 uM
HmCl
12.5 wM 25 AM
1 1,000 54 83 62 72
3,000 36 42 29 43
2 1,000 57 95 126 158
3,000 38 60 112 1381136
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nm and also at 405 nm. The latter wavelength correspondsto thewavelength ofmax-
imum absorption in the Soret absorption band characteristic of the heme moiety.
It can be seen that the heme group eluted with the major protein peak indicating
that astable heme-protein complex waspresent in theHmCl/cRPMI solution which
remained complexed throughout the chromatographic procedure (unbound heme
would elute in the salt peak).
PAGE was then carried out under nonreducing conditions on a solution of
HmCl/cRPMI to identify the protein species to which the heme moiety was com-
plexed. In the absence of SDS, the heme moiety (which couldbe visualized without
staining due to its red color was observed to have an Rf value of 0.29. After staining
with Coommassie Blue R, a protein band (Rfvalue of 0.29) was apparent in the
exact position at which the heme was observed. In addition, a pure preparation of
standard BSA run on the same gel also was observed to have an RF value of 0.29.
Therefore, as BSA is the major protein species in FCS, it seems likely that the heme
moiety forms a stable complex with BSA when dissolved in mediacontaining FCS.
Furthermore, this complex does not appear to be covalently bound as the hemeprotein
complex was observed to dissociate in polyacrylamide gels containing SDS.
Discussion
The immunogenicity of cyt c has been extensively studied in many laboratories
leading to the identification of dominant T cell epitopes on the protein backbone
of cyt c from several species. The region 88-104 of pigeon cyt c has been shown to
be an immunodominant epitope when presented in the context of the I-Ek MHC
heterodimer (1, 27) Corradin and co-workers (29) have shown that distinct I-Ab re-
stricted T cell epitopes lie within the regions 1-39 and 39-53 of apo-horse cyt c.
Also BALB/c T cells (H-2d) recognize epitopes within the regions 13-38 and 1-25
of apo-bov cyt c (28). Until this report, however, there has been no investigation
into the immunologicalproperties of theheme moiety of cyt c. As it is not aprotein
and bears no amino acid residues (see Fig. 6), one would predict, on the basis of
current models ofTcell epitopes (1, 3, 41) that such asmal molecule wouldbe poorly
immunogenic, if at all. However, data presented here clearly demonstrate that the
heme moiety can induce a vigorous and specific proliferative response (in vitro) in
nylon wool-enriched LN T cell populations from SJL mice primed with bov cyt c
(Fig. 1 a) or B10.A mice primed with pigeon cyt c (Table I). More unexpected was
the observation that an equivalent response was induced by HmCl in LN T cell
populationsderivedfrom SJL andB10.A mice immunized only with PBS/CFA(Fig.
1 b and Table I, respectively), suggesting the existenceof aheme-specific auto-reactive
T cell population within these mouse strains.
That theheme moiety behavedas aclassic MHC, class II-restricted T cell epitope
was shown in TableI, wherehigh responsiveness wascorrelated with congenic mouse
strains expressing either the I-As or I-Ak heterodimers. H-2b- and H2d-bearing
strains displayed no capacity to recognize HmCl. The ability of the anti-I-A' mAb
(MK-S4) to specifically block the T cell proliferative response to HmCI (Fig. 2, a
and b provided strong evidence that the heme group must interact directly with the
I-A' heterodimer in order to promote recognition by the appropriate TCR and in-
duce the subsequent proliferation event. Similarly, the anti I-Ak antibody (10-2.16)
specifically inhibited the heme-induced proliferative response in B10.A LN T cellCH,
￿
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The molecular structure of the heme moiety of cyt c.
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populations (Fig. 2, c and d). The inability of the B10.A T cell hybridoma, 2H10,
specific for the pigeon cyt c sequence 88-104, to produce IL-2 in response to HmCl,
provides convincing evidence that the heme moiety did not achieve its effect by an
indirect and/or nonspecific interation with T cells from the high responder haplo-
types. As it was shown that in culture, the heme group formed a stable complex
with BSA present in FCS, it was possible the immunogenic species recognized in
our assays was the heme moiety coupled to a peptide fragment of BSA produced
by intracellular processing. However, the heme moiety could be presented by
paraformaldehyde-fixed presenting cells (Fig. 3). Therefore, no processing eventwas
required for heme presentation. In addition, the removal of the heme moiety from
both bov cyt c and bov cyt c (1-65) resulted in the abrogation of the ability of these
antigens to stimulateproliferation in LN T cells from either bov cytc- or PBS-primed
SJLs (Fig. 4, a and b) indicating that the heme moiety per se was the stimulating
epitope within these antigens. Thus, it seems unlikely that BSA or BSA peptides
play a role in the T cell recognition of the heme moiety.
The structureof theheme group is shown in Fig. 6. It is a flat molecule comprised
of four pyrrole groups linked by methene bridges to form a tetrapyrrole ring hav-
ing the dimension of 9A x 9A . To the ring structure are attached four methyl
(C113), two vinyl (-CH=CH2) and two propionyl (-CH2-CH2-COO-) groups. When
the heme group forms the prosthetic group of cyt c, the central iron atom of the
heme forms ahexa-coordination complex. Four ofthecoordination positionsaround
the iron atom are occupied by the nitrogen atoms of the pyrrole rings. The sulphur
atom from methionine 80 occupies the fifth site, while the sixth position is taken
up by thering nitrogen from histidine 18 of thepolypeptide backbone. In the assays
described here, the free heme moiety was used in the oxidized form (Fe3+ ) with Cl-
occupying the fifth coordination site.
Recently, the X-ray crystallographic structure of a human class I antigen (HLA-
A2) has been determined (42, 43). A large groove at the top of the molecule com-
prising both the a1 and a2 domains of the class I molecule wastentatively identified
as the site of recognition for processed peptides. The groove was found to be 25 A
long, 10 A wide, and 11 A deep. As both class I- and II-restricting elements are
recognized by the same TCR structure and share a number of sequence homolo-
gies, it is likely that the three dimensional structure of the class II heterodimer will1138
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be similar to that described for the class I complex. Ifthat is the case, thenthe heme
moiety (9A x 9A) could fit into a binding site of the dimensions described for the
proposed antigen-binding siteofHLA-A2. The propionylgroups ofthe hemewould
be available to form hydrogen bonds with adjacent side chains within the groove.
Hydrophobic interactions are also possible between substituent groups ofthe heme
and amino acid side chains bearing ring structures (i.e., tryptophan, histidine, and
tyrosine). In addition, the fifth and sixth coordination sites ofthe central iron atom
could also interact with appropriately positioned side chains. Obviously, since the
heme/I-A complex canbe recognized by TCRsofcorrect specificity, the hememoiety
must be able to interact with amino acid residues from both I-A-binding site and
TCR simultaneously.
The interaction of a small, nonprotein molecule with a restricted set ofclass II
heterodimers, resulting in the formation of a complex capable ofbeing recognized
byTCRsofcorrectspecificity, has also been observedin the tyrosine-azobenzenear-
sonate response by class II-restricted Tcell clones (44). This example, together with
the observations reported here require that the current models describing the na-
ture ofT cell epitopes be modified. Such models propose that the immunogenicity
of a given peptide fragment is governed by the ability of that peptide to interact
simultaneouslywith the appropriate MHC-restriction element andthe specific TCR
complex. The structural constraints ofthis interaction have been dissected for a se-
ries of immunogenic peptides derived from protein antigens such as cyt c (1, 27,
39), hen egg-white lysozyme (4), and myoglobin (41). Amino acid residues thathave
been identified as either TCR orlamolecule contactresidues are interspersed along
the immunogenic fragment whose minimum length for immunological activity ap-
pears to be 10-12 amino acid residues. Nonconservative substitutions at such res-
idue positions result in either lack ofTCR recognition or an inability ofthe peptide
to interact with the appropriate la molecule, respectively. On the basis ofthese ex-
perimental observations, several models havebeen putforwardto generalize thephys-
ical nature ofa T cell epitope. Thus, Berzofsky and colleagues (41, 45) contend that
immunogenic peptides have a strong propensity to form an amphipathic a helix such
that the residues contacting the TCR lie on the hydrophillic face ofthe helix, while
the la contact residues are arranged on the hydrophobic face. Alternatively, Roth-
bard et al. (46) propose that the T cell epitopes contain a four-amino acid motif
common to many immunological peptides so far studied. Clearly, the heme moiety
ofcyt c does not comply with the above requirements. Although, ifmore than one
heme group occupied the same Ia-binding site, then the array ofsubstituent groups
ofthe ring structures may mimic the display of amino acid residue side chains of
a peptide.
Further evidence to support the contention that the free heme moiety, per se, in-
duces the vigorous proliferative response observed comes from experiments using
paraformaldehyde-fixed APC (Fig. 3). In contrast to the whole bov cyt c molecule,
the heme moiety could be effectivelypresentedby fixed APC indicating thatit could
interact directly with the I-A heterodimer without further intracellular processing
or modification. Since it has now been well established that in most cases protein
antigens in their native conformation cannot be presented to T cells in a recogniz-
able form by fixedAPC (5), one would expect to observe the loss ofTcell prolifera-
tion to bov cyt c when using paraformaldehyde-fixed APC (Fig. 3). However, weCOOPER ET AL.
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were surprised to find that the heme containing peptide bov (1-65) could not be
presented by fixed APC, indicatingthat this fragment needed to be further processed
before the T cell epitope was revealed.
Apo-bov cyt c and apo-bov (1-65) were then used as stimulating antigens to deter-
mine whether the actual T cell proliferative responses induced by the whole cyt c
molecule and by bov (1-65) were derived from the direct recognition of the heme
moiety within these antigens, or, were directed to epitopes on the polypeptide back-
bone. Fig. 4, a and b clearly show that the removal of the heme moiety from these
antigens resulted in the abrogation of the cyt c-specific, in vitro, proliferative re-
sponse by LN T cells from both bov cyt c- and PBS-primed SJLs. Therefore, this
data provides convincing evidence that the immunologically active epitope of bov
cyt c recognized by SJL LN T cells in our in vitro assay is the heme moiety per
se. As the prosthetic group ofcyt c, the heme moiety is covalently bound to the poly-
peptide backbone via cysteine residues at positions 14 and 17 . The inability of the
heme to be presented by fixed APC, in the more exposed context of the denatured
CNBr cleavage fragment, bov (1-65) (Fig. 3) further supports the contention that
the heme moiety, in the absence of an amino acid residue, is the stimulating epitope.
Thus, it seems likely that the heme molecule alone is capable of interacting with
the peptide binding domain of the I-AS heterodimer and that the remaining, free
substituent groups of the pyrrole ring are recognized by appropriate amino acid
residues of the TCR with a significant affinity. It is possible that after intracellular
processing of the cyt c molecule the heme moiety is recognized by the appropriate
TCR in conjunction with a small number ofamino acid residues deriving from the
polypeptide chain ofthe protein. However, we believe that this is unlikely since free
heme can be presented by fixed APC (Fig. 3, a and b). Furthermore, the proliferative
response induced by either bov cyt c or bov (1-65) did not achieve the magnitude
of the response stimulated by an equimolar concentration of free heme (Figs. 1, 3,
and 4). This significant reduction in the immunological activity ofthe heme moiety
when sequestered within the framework of the polypeptide chain may be due to an
inability ofthe APC to efficiently process the protein such that the free heme group
is available to interact with the class 11-restricting element. Alternatively, only a
small fraction of the heme may enter the correct intracellular compartment for in-
teraction with la, after the processing event has taken place.
The heme moiety of cyt c is also the prosthetic group for the oxygen-binding pro-
teins myoglobin and hemoglobin and, therefore, is a ubiquitous self molecule. As
has been demonstrated, the heme moiety induces a vigorous proliferative response
(in vitro) in LN T cells obtained from naive animals of the higher responder haplo-
types demonstrating the existence of an auto-reactive heme-specific T cell popula-
tion. Furthermore, the magnitude of the response suggests that the frequency of
T cells within the polyclonal population able to recognize the heme moiety is sur-
prisingly high. Since the heme molecule is small, one would expect that very few
reactive groups would be available for interaction with the TCR once the heme has
complexed with the appropriate la molecule, thereby significantly reducing the struc-
tural constraints for such an interaction. It is possible that the heme molecule is
a highly permissive structure for T cell recognition and would be able to fit the binding
site from TCRs of quite diverse specificity, analogous to hapten recognition by Igs.
As a consequence of the limited number of reactive groups on the heme molecule,1140
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one might predict that the affinity of the TCR for the heme-la complex may be
relatively low. Therefore, only under conditions where theconcentration of the free
heme moiety and, therefore, theheme-Ia complex, is high could activation ofheme-
specific T cell clones occur. Such conditions are met in our in vitro culture system.
In vivo, however, the heme moiety is sequestered within the framework of the pro-
tein molecule and, hence, high concentrations (in vivo) of free heme would never
be attained. We anticipate, therefore, that the heme-specific T cell population de-
scribed in this study is quiescent in vivo even though this T cell population has es-
caped tolerance induction. In addition, an active regulatory mechanism such as a
suppressor T cell network may also be operative. It has been shown that the
phenomenon of B cell tolerance is affinity dependent(47). Thus, the hypothesis has
been put forward that those immature B cells whose affinity for self antigen falls
below the threshold for tolerance induction would escape functional deletion (47) .
A similar mechanism has also been proposed to account for the existence of self-
reactive Tcell populations. Wood et al. (24) have demonstrated that tolerogen-specific
cytotoxic T cells present in neonatally tolerant mice are low avidity cells that have
preferentially escapedclonal deletion. Thus, theauto-reactiveTcell population demon-
stratedhere may have escaped toleranceinduction due to itslow affinity forthe heme
moiety.
Summary
In these studies, we have shown that the heme moiety of cyt c is a dominant T
cell epitope that induces a large proliferative response in lymph node T cells derived
from SJL andB10.A mice when presented on either unfixed or fixed syngeneicAPCs.
Not only is this vigorous response observed for cyt c-primed T cell populations but
also for populations obtained from naive SJL or B10.A mice. The reactivity to the
heme moiety falls under strict MHC restriction, in that it is present only in murine
strains bearing either the I-A' or I-As molecule and can be blocked by antibodies
specific for these class II molecules. Therefore, these findings require that the cur-
rent models describing the nature ofT cell epitopes be extended to include nonpep-
tide molecules. Furthermore, as the heme moiety is ubiquitous throughout the or-
ganism, although sequestered within proteins, the existence of heme-reactive T cell
populations in unprimed animals provides anotherexample of the existence of self-
reactive T cell clones.
Receivedfor publication 3 March 1988 and in revisedform 17 May 1988.
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